{
    "code": "01056683",
    "time": "2015-06-25 05:33:15",
    "許可證字號": "衛署藥製字第056683號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/08\/22",
    "發證日期": "100\/08\/22",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105668302",
    "中文品名": "\"台灣神隆\"凱希得平",
    "英文品名": "Capecitabine \"SPT\"",
    "適應症": "Capecitabine可治療轉移性大腸（結腸直腸）癌病患。Capecitabine可作為第三期結腸癌患者手術後輔助性療法。Capecitabine與Docetaxel併用於治療對Anthracycline化學治療無效之局部晚期或轉移性乳癌病患。Capecitabine亦可單獨用於對紫杉醇（Taxane）及Anthracycline化學治療無效，或無法使用Anthracycline治療之局部晚期或轉移性乳癌病患。Capecitabine合併Platinum可使用於晚期胃癌之第一線治療。",
    "劑型": "040（粉）",
    "包裝": "0.5公斤以上HDPE圓桶裝",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "主成分略述": "",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1437920200  臺灣神隆股份有限公司",
    "申請商地址": "台南市善化區台南科學園區南科八路１號",
    "主製造廠": {
        "製造廠名稱": "1437920300  臺灣神隆股份有限公司",
        "製造廠廠址": "台南市善化區台南科學園區南科八路１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "29335990900 其他之結構中含嘧啶環（不論是否氫化）或六氫？？環之化合物Other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure",
    "藥理治療分類": "",
    "ingredients": [

    ],
    "仿單外盒": [
        {
            "title": "仿單 5-2 SPT1241 中文標籤2 (依照DOH修改後)___20110926.doc 5-1 仿單標籤粘貼表-20110915___20110926.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01056683&Seq=002&Type=9"
        },
        {
            "title": "外盒 5-3___20110926.(背面) Packagin material_HDPE Bottle照片-update.ppt 5-1 仿單標籤粘貼表-20110915___20110926.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01056683&Seq=002&Type=8"
        }
    ]
}